To: blake1 who wrote (1252 ) 3/8/1998 7:45:00 PM From: David S. Respond to
I cannot get any firm to publish a report, that thought is absurd. If I were to take the time to write a report on chromatic, it would be longer than the Avalon report, and would have gone into greater detail. sprx product was introduced to the medical cmty a few months ago. Pipeline filling is occurring at this moment. what is interesting is that sprx pipeline filling is with a handheld portable device, something ccsi is trying to create. I recall a darby quote by janybird saying regarding ccsi, that their technology didn't work in the past and there's no guarantee it'll work now, or something along those lines. do you realize how moronic that statement is - that the technology didn't work in the past? how about the chromogenic diseases? why is ccsi the only company on the planet talking about them? If the potential were there, do you think other firms would at least discuss it? Perhaps you'd like to cite a 10 year old article about color and tuberculosis - that was a decade ago, time and technology marches on. Perhaps you believe distributors work for free? Or didn't anyone spoon feed you the fact that a distributor can take big piece of revenues, hence profits from device sales. Advisory boards are common in the device and drug area. In all areas of medicine, there are competitive products and modalities. People do not decide not to be an advisor just because there are alternative treatments or tools out there. Fred Frank runs their healthcare investment banking dept., and like I guessed before it happened, it was his idea to split the stock. wow, I'm impressed. Lehman also was hired by Organogenesis, and last year took public a company that has reformulated crazy glue for replacing stitches. Another doozy. You might want to get short that crazy glue stock too. Lehman is trying to prop it up too. It's called Closure Medical. symbol CLSR. Mr Frank is human. He cannot turn lead into gold, and cannot turn a sow's ear into a silk purse.
